entinostat has been researched along with Plasma Cell Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simmons, JK | 1 |
| Patel, J | 1 |
| Michalowski, A | 1 |
| Zhang, S | 1 |
| Wei, BR | 1 |
| Sullivan, P | 1 |
| Gamache, B | 1 |
| Felsenstein, K | 1 |
| Kuehl, WM | 1 |
| Simpson, RM | 1 |
| Zingone, A | 1 |
| Landgren, O | 1 |
| Mock, BA | 1 |
1 other study available for entinostat and Plasma Cell Tumor
| Article | Year |
|---|---|
TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms.
Topics: Animals; Benzamides; Cell Line, Tumor; Histone Deacetylase Inhibitors; Humans; Lymphoma, B-Cell; Mec | 2014 |